Segmentation by type classifies medical air purifiers into HEPA‑filter, UV‑C, ionic, activated‑carbon, and hybrid systems, each addressing specific contaminant profiles. HEPA filters, capturing particles down to 0.3 µm with 99.97 % efficiency, command the largest share (approximately 55 %) owing to their proven efficacy against bacteria and viruses across all application settings. UV‑C units, contributing around 20 % of sales, inactivate microorganisms through germicidal irradiation, making them valuable as a secondary barrier in high‑risk zones like operating rooms. Ionic purifiers, at 10 %, generate charged particles to precipitate aerosols, suitable for low‑to‑moderate traffic areas but limited by ozone concerns. Activated‑carbon filters, representing 8 %, excel at adsorbing volatile organic compounds and odors, often paired with HEPA media in surgical suites. Hybrid configurations, integrating two or more technologies, occupy the remaining 7 % and are favored in environments requiring comprehensive control of both particulate and gaseous pollutants, thereby influencing overall market dynamics.